Category: Multidrug Transporters

protease inhibitor

Moreover, it has been reported that patients with mutations may respond differently to treatments depending on the mutation class

Moreover, it has been reported that patients with mutations may respond differently to treatments depending on the mutation class. Colorectal cancer (CRC) is one of the most common cancers, with an associated mortality rate of 9.2% that makes it the second leading cause of cancer-associated deaths (1). Early-stage CRC can be curable under surgery, whereas…
Read more

The chimeric protein was tested against anti-RmLTI-BmCG-LTB bovine sera (diluted 1:800)

The chimeric protein was tested against anti-RmLTI-BmCG-LTB bovine sera (diluted 1:800). The portions from the recombinant protein corresponding to the RmLTI and Bm86-CG proteins in this study contained 269 of 373 a.a., including the linker-fused epitopes, the histidine tail, and the LTB (104 a.a.) (Table 1). vaccines TickGardPLUS (Intervet Australia) and Gavac? (Heber Biotec S.A.,…
Read more